Mattias Giovanni Fili
Founder at EXEGER Sweden AB
Profile
Mattias Giovanni Fili is the founder and current Director of Sigrid Therapeutics AB and Atrogi AB.
He founded EXEGER Sweden AB in 2009 and serves as its Chief Executive Officer & Director.
Mattias Giovanni Fili active positions
Companies | Position | Start |
---|---|---|
EXEGER Sweden AB
EXEGER Sweden AB Building ProductsProducer Manufacturing EXEGER Sweden AB operates as a screen printing solar cell factory. It also commercializing solar technology. The company was founded by Giovanni Fili in 2009 and is headquartered in Stockholm, Sweden. | Founder | 2008-12-31 |
Sigrid Therapeutics AB
Sigrid Therapeutics AB Medical SpecialtiesHealth Technology Sigrid Therapeutics AB engages in research and development in the area of weight loss and metabolic disorders. It focuses on therapies for prevention and treatment of lifestyle diseases. The company was founded by Sana Alajmovic and Tore Bengtsson in 2014 and is headquartered in Stockholm, Sweden. | Director/Board Member | - |
Atrogi AB
Atrogi AB BiotechnologyHealth Technology Atrogi AB engages in research and development & sells type 2 diabetes (T2D) with minimal side effects. The company was founded by Tore Bengtsson and Andreas Bhagwani in 2013 and is headquartered in Solna, Sweden. | Director/Board Member | 2012-12-31 |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 3 |
---|---|
EXEGER Sweden AB
EXEGER Sweden AB Building ProductsProducer Manufacturing EXEGER Sweden AB operates as a screen printing solar cell factory. It also commercializing solar technology. The company was founded by Giovanni Fili in 2009 and is headquartered in Stockholm, Sweden. | Producer Manufacturing |
Sigrid Therapeutics AB
Sigrid Therapeutics AB Medical SpecialtiesHealth Technology Sigrid Therapeutics AB engages in research and development in the area of weight loss and metabolic disorders. It focuses on therapies for prevention and treatment of lifestyle diseases. The company was founded by Sana Alajmovic and Tore Bengtsson in 2014 and is headquartered in Stockholm, Sweden. | Health Technology |
Atrogi AB
Atrogi AB BiotechnologyHealth Technology Atrogi AB engages in research and development & sells type 2 diabetes (T2D) with minimal side effects. The company was founded by Tore Bengtsson and Andreas Bhagwani in 2013 and is headquartered in Solna, Sweden. | Health Technology |
- Stock Market
- Insiders
- Mattias Giovanni Fili